Studying SCTB41 for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called SCTB41 in people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it shrinks tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed advanced solid tumor that has spread or cannot be removed with surgery
- You are 18 years or older
- You are expected to live at least 3 more months
- You are able to take care of yourself (ECOG score of 0 or 1)
- Your organs and bone marrow are working well enough
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SCTB14 in adults with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and may help shrink or control the cancer.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests a new drug (SCTB41) combined with chemotherapy for people with advanced squamous non-small cell lung cancer who have not had any prior treatment. It aims to see if this combination works better than standard therapy.
This study tests an experimental drug called SKB571 for people with advanced solid tumors that have not responded to or stopped responding to standard treatments. The goal is to see if SKB571 is safe and to find the right dose.
This trial tests a new drug called MHB042C for people with advanced solid tumors that have stopped responding to other treatments. It aims to see if the drug is safe and effective.
This trial tests a new drug called SCTB39-1 for people with advanced solid tumors that have not responded to other treatments. The study has two parts: first finding the right dose, then testing how well it works.
Hear when a new Advanced Malignant Solid Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.